Improving dialysis through design
Faculty from the McKelvey School of Engineering and the School of Medicine teamed up to design better grafts for dialysis patients.
Judy and Jerry Kent to receive Harris Award
Judy and Jerry Kent have been selected as the 2021 recipients of the Jane and Whitney Harris St. Louis Community Service Award for their contributions to the St. Louis community.
Another honor for university’s sustainable building practice
The U.S. Green Building Council awarded Washington University a 2021 Leadership Award for excellence in its West North Central Region.
Study sheds light on treatment options for devastating childhood brain cancer
A new study led by Washington University School of Medicine provides new guidance on the treatment of medulloblastoma, a pediatric brain cancer. Some aspects of radiation therapy may be reduced while still providing effective treatment.
Washington University’s College Prep Program welcomes eighth cohort
Washington University has admitted 47 rising high school sophomores to its innovative College Prep Program, a multiyear initiative that prepares high-achieving students with limited financial resources for college.
Laughing gas relieves symptoms in people with treatment-resistant depression
Researchers at the School of Medicine and the University of Chicago have found that a single, one-hour treatment that involves breathing in laughing gas can significantly improve symptoms in people with treatment-resistant depression.
Global travelers pick up numerous genes that promote microbial resistance
New School of Medicine research shows that international travelers often return home with new bacterial strains jostling for position within the gut microbiome. Such travel is contributing to the rapid global increase and spread of antimicrobial resistance.
Board grants faculty appointments, promotions, tenure
At the Washington University in St. Louis Board of Trustees meeting May 7, numerous faculty members were appointed or promoted with tenure or granted tenure, with most effective July 1.
Newly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.
Studies reveal skull as unexpected source of brain immunity
Researchers at Washington University School of Medicine have discovered that the immune cells stationed in the protective tissue known as the meninges come primarily from the skull. The finding opens up the possibility of developing therapies to target such cells as a way to prevent or treat brain conditions.
View More Stories